Artivion | CRY - Cost Of Sales


Artivion reported $42.85M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 35.16M 2.23M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Boston Scientific USD 1.84B 82M Dec/2025
Edwards Lifesciences USD 343M 2.2M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Integra LifeSciences USD 193.44M 1.62M Dec/2025
J&J USD 7.97B 689M Dec/2025
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Orthofix International USD 66.63M 6.4M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
ResMed USD 555.85M 29.13M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Surmodics USD 9.49M 23.54M Jun/2025
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 261.54M 199.84M Dec/2025
Terumo JPY 143.44B 15.47B Dec/2025
Trinity Biotech USD 7.84M 3.14M Sep/2025